Bo Angelin

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Professor i klinisk metabolisk forskning.

Leder Integrated Cardio Metabolic Centre (ICMC), ett forskningscenter som drivs gemensamt av Karolinska Institutet och AstraZeneca.

Artiklar

Article: ATHEROSCLEROSIS. 2024;389:117439
Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemia
Wodaje T; Mahdi A; Venkateshvaran A; Habel H; Zenlander R; Gaylard B; Angelin B; Pernow J; Brinck J
Article: HEPATOLOGY. 2023;78(3):709-726
A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans
Caballero-Camino FJ; Rodrigues PM; Wangsell F; Agirre-Lizaso A; Olaizola P; Izquierdo-Sanchez L; Perugorria MJ; Bujanda L; Angelin B; Straniero S; Walleback A; Starke I; Gillberg P-G; Strangberg E; Bonn B; Mattsson JP; Madsen MR; Hansen HH; Lindstrom E; Akerblad P; Banales JM
Article: COMMUNICATIONS BIOLOGY. 2022;5(1):1057
Molecular programming modulates hepatic lipid metabolism and adult metabolic risk in the offspring of obese mothers in a sex-specific manner
Savva C; Helguero LA; Gonzalez-Granillo M; Melo T; Couto D; Angelin B; Domingues MR; Li X; Kutter C; Korach-Andre M
Article: JOURNAL OF INTERNAL MEDICINE. 2021;290(2):404-415
Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia
Benedek P; Jiao H; Duvefelt K; Skoog T; Linde M; Kiviluoma P; Kere J; Eriksson M; Angelin B
Article: COMMUNICATIONS BIOLOGY. 2021;4(1):14
Obese mother offspring have hepatic lipidic modulation that contributes to sex-dependent metabolic adaptation later in life
Savva C; Helguero LA; Gonzalez-Granillo M; Couto D; Melo T; Li X; Angelin B; Domingues MR; Kutter C; Korach-Andre M
Article: JOURNAL OF INTERNAL MEDICINE. 2020;287(5):534-545
Regulation of bile acid metabolism in biliary atresia: reduction of FGF19 by Kasai portoenterostomy and possible relation to early outcome
Johansson H; Svensson JF; Almstrom M; Van Hui N; Rudling M; Angelin B; Nowak G; Fischler B; Ellis E
Article: JOURNAL OF LIPID RESEARCH. 2020;61(4):480-491
Of mice and men: murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism[S]
Straniero S; Laskar A; Savva C; Hardfeldt J; Angelin B; Rudling M
Article: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2020;502:110672
Selective estrogen receptor (ER)β activation provokes a redistribution of fat mass and modifies hepatic triglyceride composition in obese male mice
Gonzalez-Granillo M; Savva C; Li X; Laskar MG; Angelin B; Gustafsson J-A; Korach-Andre M
Article: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2020;10(1):149-170
A Physiology-Based Model of rile Acid Distribution and Metabolism Under Healthy Pathologic Conditions in Human Beings
Voronova V; Sokolov V; Al-Khaifi A; Straniero S; Kumar C; Peskov K; Helmlinger G; Rudling M; Angelin B
Article: JOURNAL OF INTERNAL MEDICINE. 2018;284(5):546-559
Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism
Al-Khaifi A; Straniero S; Voronova V; Chernikova D; Sokolov V; Kumar C; Angelin B; Rudling M
Article: GASTROENTEROLOGY. 2018;155(4):1012-1016
An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy Volunteers
Al-Khaifi A; Rudling M; Angelin B
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2017;313(2):E167-E174
Cholestyramine treatment of healthy humans rapidly induces transient hypertriglyceridemia when treatment is initiated
Sjoberg BG; Straniero S; Angelin B; Rudling M
Article: JOURNAL OF INTERNAL MEDICINE. 2017;281(6):575-585
Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III
Laskar MG; Eriksson M; Rudling M; Angelin B
Article: CLINICAL OBESITY. 2017;7(1):1-10
Mental distress in treatment seeking young adults (18-25 years) with severe obesity compared with population controls of different body mass index levels: cohort study
Dreber H; Reynisdottir S; Angelin B; Tynelius P; Rasmussen F; Hemmingsson E
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2017;47(1):38-43
High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia
Frias MA; Thomas A; Brulhart-Meynet M-C; Kovamees O; Pernow J; Eriksson M; Angelin B; James RW; Brinck JW
Article: JOURNAL OF INTERNAL MEDICINE. 2016;279(5):477-484
Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels
Kovamees O; Shemyakin A; Eriksson M; Angelin B; Pernow J
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2016;36(5):787-791
Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus-Brief Report
Apro J; Tietge UJF; Dikkers A; Parini P; Angelin B; Rudling M
Article: PLOS ONE. 2016;11(2):e0148802
Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans
Lehtihet M; Bonde Y; Beckman L; Berinder K; Hoybye C; Rudling M; Sloan JH; Konrad RJ; Angelin B
Article: PLOS ONE. 2015;10(12):e0145273
Who is the Treatment-Seeking Young Adult with Severe Obesity: A Comprehensive Characterization with Emphasis on Mental Health
Dreber H; Reynisdottir S; Angelin B; Hemmingsson E
Article: JOURNAL OF LIPID RESEARCH. 2015;56(8):1633-1639
Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients
Apro J; Parini P; Broijersen A; Angelin B; Rudling M
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2015;461(4):592-597
Influence of dietary sugar on cholesterol and bile acid metabolism in the rat: Marked reduction of hepatic Abcg5/8 expression following sucrose ingestion
Apro J; Beckman L; Angelin B; Rudling M
Article: JOURNAL OF INTERNAL MEDICINE. 2015;277(3):331-342
Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome
Angelin B; Kristensen JD; Eriksson M; Carlsson B; Klein I; Olsson AG; Ridgway EC; Ladenson PW
Article: JOURNAL OF LIPID RESEARCH. 2015;56(2):463-469
Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol
Ghosh M; Gaelman C; Rudling M; Angelin B
Article: JOURNAL OF LIPID RESEARCH. 2014;55(11):2408-2415
Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans
Bonde Y; Breuer O; Luetjohann D; Sjoberg S; Angelin B; Rudling M
Article: JOURNAL OF INTERNAL MEDICINE. 2013;274(3):227-232
Influence of growth hormone on circulating fibroblast growth factor 21 levels in humans
Lundberg J; Hoybye C; Krusenstjerna-Hafstrom T; Bina HA; Kharitonenkov A; Angelin B; Rudling M
Article: CELL METABOLISM. 2013;17(2):225-235
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
Sayin SI; Wahlstrom A; Felin J; Jantti S; Marschall H-U; Bamberg K; Angelin B; Hyotylainen T; Oresic M; Backhed F
Article: HEPATOLOGY. 2012;56(5):1828-1837
Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complex
Bonde Y; Plosch T; Kuipers F; Angelin B; Rudling M
Article: CLINICAL CHEMISTRY. 2012;58(8):1225-1232
Circulating Human Hepcidin-25 Concentrations Display a Diurnal Rhythm, Increase with Prolonged Fasting, and Are Reduced by Growth Hormone Administration
Troutt JS; Rudling M; Persson L; Stahle L; Angelin B; Butterfield AM; Schade AE; Cao G; Konrad RJ
Article: PLOS ONE. 2012;7(5):e37787
Inhibition of Intestinal Bile Acid Transporter Slc10a2 Improves Triglyceride Metabolism and Normalizes Elevated Plasma Glucose Levels in Mice
Lundasen T; Andersson E-M; Snaith M; Lindmark H; Lundberg J; Ostlund-Lindqvist A-M; Angelin B; Rudling M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2012;32(3):810-814
Endogenous Estrogens Lower Plasma PCSK9 and LDL Cholesterol But Not Lp(a) or Bile Acid Synthesis in Women
Persson L; Henriksson P; Westerlund E; Hovatta O; Angelin B; Rudling M
Article: JOURNAL OF INTERNAL MEDICINE. 2011;270(6):580-588
Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19
Galman C; Angelin B; Rudling M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2010;30(12):2666-2672
Circulating Proprotein Convertase Subtilisin Kexin Type 9 Has a Diurnal Rhythm Synchronous With Cholesterol Synthesis and Is Reduced by Fasting in Humans
Persson L; Cao G; Stahle L; Sjoberg BG; Troutt JS; Konrad RJ; Galman C; Wallen H; Eriksson M; Hafstrom I; Lind S; Dahlin M; Amark P; Angelin B; Rudling M
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2010;362(10):906-916
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
Ladenson PW; Kristensen JD; Ridgway EC; Olsson AG; Carlsson B; Klein I; Baxter JD; Angelin B
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2009;29(8):1235-1241
Control of ACAT2 Liver Expression by HNF4α Lesson From MODY1 Patients
Pramfalk C; Karlsson E; Groop L; Rudel LL; Angelin B; Eriksson M; Parini P
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2009;38(3):184-189
Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease
Hua X; Su J; Svenungsson E; Hurt-Camejo E; Jensen-Urstad K; Angelin B; Bvenholm P; Frostegrd J
Article: ENDOCRINOLOGY. 2009;150(3):1140-1146
Importance of Proprotein Convertase Subtilisin/Kexin Type 9 in the Hormonal and Dietary Regulation of Rat Liver Low-Density Lipoprotein Receptors
Persson L; Galman C; Angelin B; Rudling M
Article: CELL METABOLISM. 2008;8(2):169-174
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man
Gaelman C; Lundasen T; Kharitonenkov A; Bina HA; Eriksson M; Hafstroem I; Dahlin M; Amark P; Angelin B; Rudling M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2008;28(6):1200-1206
Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2
Parini P; Gustafsson U; Davis MA; Larsson L; Einarsson C; Wilson M; Rudling M; Tomoda H; Omura S; Sahlin S; Angelin B; Rudel LL; Eriksson M
Article: GASTROENTEROLOGY. 2008;134(4):1127-1136
Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone
Galman C; Bonde Y; Matasconi M; Angelin B; Rudling M
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2008;105(2):663-667
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans
Berkenstam A; Kristensen J; Mellstrom K; Carlsson B; Malm J; Rehnmark S; Garg N; Andersson CM; Rudling M; Sjoberg F; Angelin B; Baxter JD
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2007;364(2):402-409
Cholesterol regulates ACAT2 gene expression and enzyme activity in human hepatoma cells
Pramfalk C; Angelin B; Eriksson M; Parini P
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2007;293(3):E737-E742
Age-induced hypercholesterolemia in the rat relates to reduced elimination but not increased intestinal absorption of cholesterol
Gaelman C; Matasconi M; Persson L; Parini P; Angelin B; Rudling M
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2007;360(2):437-440
PPARα is a key regulator of hepatic FGF21
Lundasen T; Hunt MC; Nilsson L-M; Sanyal S; Angelin B; Alexson SEH; Rudling M
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2007;357(3):707-711
Bile acids and lipoprotein metabolism: Effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression
Nilsson L-M; Abrahamsson A; Sahlin S; Gustafsson U; Angelin B; Parini P; Einarsson C
Article: JOURNAL OF INTERNAL MEDICINE. 2006;260(6):530-536
Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man
Lundasen T; Galman C; Angelin B; Rudling M
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2006;36(2):98-104
Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system
Parini P; Johansson L; Bröijersén A; Angelin B; Rudling M
Article: GASTROENTEROLOGY. 2005;129(5):1445-1453
Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis
Gälman C; Angelin B; Rudling M
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2005;1736(3):221-227
Pituitary control of cholesterol metabolism in normal and LDL receptor knock-out mice: Effects of hypophysectomy and growth hormone treatment
Matasconi M; Panini P; Angelin B; Rudling M
Article: ATHEROSCLEROSIS. 2005;182(1):37-45
Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentration
Abrahamsson A; Krapivner S; Gustafsson U; Muhrbeck O; Eggertsen G; Johansson I; Persson I; Angelin B; Ingelman-Sundberg M; Björkhem I; Einarsson C; van't Hooft FM
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2005;102(29):10297-10302
Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice
Johansson L; Rudling M; Scanlan TS; Lundåsen T; Webb P; Baxter J; Angelin B; Parini P
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2005;25(5):1057-1064
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion
Brousseau ME; Diffenderfer MR; Millar JS; Nartsupha C; Asztalos BF; Welty FK; Wolfe ML; Rudling M; Björkhem I; Angelin B; Mancuso JP; Digenio AG; Rader DJ; Schaefer EJ
Article: JOURNAL OF INTERNAL MEDICINE. 2004;256(5):406-412
Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment
Lind S; Olsson AG; Eriksson M; Rudling M; Eggertsen G; Angelin B
Article: ENDOCRINOLOGY. 2004;145(11):4897-4911
Prenatal exposure to interleukin-6 results in hypertension and increased hypothalamic-pituitary-adrenal axis activity in adult rats
Samuelsson AM; Öhrn I; Dahlgren J; Eriksson E; Angelin B; Folkow B; Holmäng A
Article: CIRCULATION. 2004;110(14):2017-2023
ACAT2 is localized to Hepatocytes and is the major cholesterol-esterifying enzyme in human liver
Parini P; Davis M; Lada AT; Erickson SK; Wright TL; Gustafsson U; Sahlin S; Einarsson C; Eriksson M; Angelin B; Tomoda H; Omura S; Willingham MC; Rudel LL
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2004;287(1):E114-E119
Pituitary control of lipoprotein and bile acid metabolism in male rats: growth hormone effects are not mediated by prolactin
Matasconi M; Angelin B; Rudling M
Article: CIRCULATION RESEARCH. 2004;94(12):1579-1588
Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice
Bråkenhielm E; Cao RH; Gao BH; Angelin B; Cannon B; Parini P; Cao YH
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2004;24(2):349-356
Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans
Lind S; Rudling M; Ericsson S; Olivecrona H; Eriksson M; Borgström B; Eggertsen G; Berglund L; Angelin B
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2003;278(44):43224-43228
Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7α-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice
Lundåsen T; Liao W; Angelin B; Rudling M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2003;105(2):266-273
Reduction in serum levels of antimitochondrial (M2) antibodies following immunoglobulin therapy in severe combined immunodeficient (SCID) mice reconstituted with lymphocytes from patients with primary biliary cirrhosis (PBC)
Abedi MR; Hammarstrom L; Broome U; Angelin B; Smith CIE; Christensson B
Article: NATURE GENETICS. 2003;34(1):29-31
Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders
Jones B; Jones EL; Bonney SA; Patel HN; Mensenkamp AR; Eichenbaum-Voline S; Rudling M; Myrdal U; Annesi G; Naik S; Meadovvs N; Quattrone A; Islam SA; Naoumova RP; Angelin B; Infante R; Levy E; Roy CC; Freemont PS; Scott J; Shoulders CC
Article: JOURNAL OF LIPID RESEARCH. 2003;44(4):859-866
Monitoring hepatic cholesterol 7α-hydroxylase activity by assay of the stable bile acid intermediate 7α-hydroxy-4-cholesten-3-one in peripheral blood
Gälman C; Arvidsson I; Angelin B; Rudling M
Article: FASEB JOURNAL. 2003;16(14):265-267
Pharmacological interference with intestinal bile acid transport reduces plasma cholesterol in LDL receptor/apoE deficiency
Gälman C; Östlund-Lindqvist AM; Björquist A; Schreyer S; Svensson L; Angelin B; Rudling M
Article: ATHEROSCLEROSIS SUPPLEMENTS. 2002;3(4):23-30
Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL
Angelin B; Parini P; Eriksson M
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2002;87(9):4307-4313
Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7α-hydroxylase mRNAs in human liver
Rudling M; Angelin B; Ståhle L; Reihnér E; Sahlin S; Olivecrona H; Björkhem I; Einarsson C
Article: CIRCULATION. 2002;106(9):1147-1153
Accumulation of foam cells in liver X receptor-deficient mice
Schuster GU; Parini P; Wang L; Alberti S; Steffensen KR; Hansson GK; Angelin B; Gustafsson J
Article: ATHEROSCLEROSIS. 2002;163(2):399-407
Genetic characterization of Swedish patients with familial hypercholesterolemia: a heterogeneous pattern of mutations in the LDL receptor gene
Lind S; Rystedt E; Eriksson M; Wiklund O; Angelin B; Eggertsen G
Article: MOLECULAR ENDOCRINOLOGY. 2002;16(8):1767-1777
Requirement for thyroid hormone receptor β in T₃ regulation of cholesterol metabolism in mice
Gullberg H; Rudling M; Saltó C; Forrest D; Angelin B; Vennström B
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2002;277(30):26804-26807
Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver -: No coordinate regulation of CYP7A1 and CYP27A1
Björkhem I; Araya Z; Rudling M; Angelin B; Einarsson C; Wikvall K
Article: ENDOCRINOLOGY. 2002;143(5):1809-1816
Prolonged stimulation of the adrenals by corticotropin suppresses hepatic low-density lipoprotein and high-density lipoprotein receptors and increases plasma cholesterol
Gälman C; Angelin B; Rudling M
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2002;1581(1-2):36-48
Dexamethasone stimulates very low density lipoprotein (VLDL) receptor gene expression in differentiating 3T3-L1 cells
Ensler K; Mohammadieh M; Bröijersén A; Angelin B; Gåfvels M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2001;21(12):2039-2045
Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia
Love MW; Craddock AL; Angelin B; Brunzell JD; Duane WC; Dawson PA
Article: FASEB JOURNAL. 2001;15(8):1350-1356
Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice
Rudling M; Angelin B
Article: JOURNAL OF CLINICAL INVESTIGATION. 2001;107(5):565-573
Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice
Alberti S; Schuster G; Parini P; Feltkamp D; Diczfalusy U; Rudling M; Angelin B; Björkhem I; Pettersson S; Gustafsson J
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2000;278(3):640-645
Obesity and disturbed lipoprotein profile in estrogen receptor-α-deficient male mice
Ohlsson C; Hellberg N; Parini P; Vidal O; Bohlooly M; Rudling M; Lindberg MK; Warner M; Angelin B; Gustafsson J
Article: MOLECULAR ENDOCRINOLOGY. 2000;14(11):1739-1749
Thyroid hormone receptor β-deficient mice show complete loss of the normal cholesterol 7α-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol
Gullberg H; Rudling M; Forrest D; Angelin B; Vennström B
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2000;30(10):866-870
LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion
Stenvinkel P; Alvestrand A; Angelin B; Eriksson M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2000;20(7):1817-1823
Biphasic effects of the natural estrogen 17β-estradiol on hepatic cholesterol metabolism in intact female rats
Parini P; Angelin B; Stavréus-Evers A; Freyschuss B; Eriksson H; Rudling M
Article: CONTROL AND CYBERNETICS. 2000;29(1):405-425
Kinetic analysis of LDL apoB transport and metabolism in non-steady states
Werynski A; Nahorski Z; Angelin B; Berglund L; Eriksson M
Journal article: UGESKRIFT FOR LAEGER. 1999;161(51):7071-7076
[Gunter Blobel, the 1999 Nobel Prize winner in physiology or medicine. Proteins in the cell are directed by built-in "zip codes"].
Pettersson RF; Angelin B; Daneholt B
Article: HEPATOLOGY. 1999;30(5):1252-1256
Endotoxin suppresses mouse hepatic low-density lipoprotein-receptor expression via a pathway independent of the Toll-like receptor 4
Liao W; Rudling M; Angelin B
Journal article: LAKARTIDNINGEN. 1999;96(42):4507-4512
[Günter Blobel the 1999 Nobel Prize-winner in physiology and medicine. Proteins are directed in the cell through by built-in "zip-codes"].
Pettersson RF; Angelin B; Daneholt B
Article: JOURNAL OF INTERNAL MEDICINE. 1999;246(4):399-407
Deoxycholic acid treatment in patients with cholesterol gallstones:: failure to detect a suppression of cholesterol 7α-hydroxylase activity
Hillebrant CG; Nyberg B; Angelin B; Axelson M; Björkhem I; Rudling M; Einarsson C
Article: CIRCULATION. 1999;100(6):594-598
Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I - Potential reverse cholesterol transport in humans
Eriksson M; Carlson LA; Miettinen TA; Angelin B
Article: PHARMACOLOGY. 1999;59(1):51-56
Heme oxygenase inhibitors transiently increase serum ferritin concentrations without altering other acute-phase reactants in man
Berglund L; Galbraith RA; Emtestam L; Drummond GS; Angelin B; Kappas A
Article: EUROPEAN JOURNAL OF PHARMACOLOGY. 1999;374(3):471-476
Endogenous histamine reduces plasma insulin-like growth factor I via H₁ receptor-mediated pathway in the rat
Liao W; Rudling M; Möller C; Angelin B
Article: JOURNAL OF LIPID RESEARCH. 1999;40(5):913-919
VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression:: involvement of the VLDL receptor
Nilsson L; Gåfvels M; Musakka L; Ensler K; Strickland DK; Angelin B; Hamsten A; Eriksson P
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1999;29(4):291-300
Evidence of circadian rhythm in low-density lipoprotein apoB catabolism and its impact on the estimation of kinetic parameters
Werynski A; Nahorski Z; Berglund L; Ericsson S; Angelin B; Eriksson M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1999;19(4):832-839
Cholesterol and lipoprotein metabolism in aging - Reversal of hypercholesterolemia by growth hormone treatment in old rats
Parini P; Angelin B; Rudling M
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1999;84(2):553-560
Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins:: Serum levels and hepatic messenger ribonucleic acid responses in humans
Olivecrona H; Hilding A; Ekström C; Barle H; Nyberg B; Möller C; Delhanty PJ; Baxter RC; Angelin B; Ekström TJ; Tally M
Article: AMERICAN JOURNAL OF PATHOLOGY. 1998;153(6):1923-1935
Lipoprotein receptors in acute myelogenous leukemia -: Failure to defect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation
Rudling M; Gåfvels M; Parini P; Gahrton G; Angelin B
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1998;1394(2-3):153-157
The level of 7-dehydrocholesterol in plasma reflects the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the human liver
Axelson M; Angelin B; Hillebrant CG; Reihner E; Einarsson C
Article: JOURNAL OF LIPID RESEARCH. 1998;39(11):2172-2181
Bovine aortic endothelial cells express a variant of the very low density lipoprotein receptor that lacks the O-linked sugar domain
Magrané J; Reina M; Pagan R; Luna A; Casaroli-Marano RP; Angelin B; Gafvels M; Vilaró S
Article: JOURNAL OF INTERNAL MEDICINE. 1998;244(1):19-25
Low frequency of the common Norwegian and Finnish LDL-receptor mutations in Swedish patients with familial hypercholesterolaemia
Lind S; Eriksson M; Rystedt E; Wiklund O; Angelin B; Eggertsen G
Article: MOLECULAR HUMAN REPRODUCTION. 1998;4(6):585-593
Degradation of urokinase plasminogen activator (UPA) in endometrial stromal cells requires both the UPA receptor and the low-density lipoprotein receptor-related protein α2-macroglobulin receptor
Casslen B; Gustavsson B; Angelin B; Gafvels M
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1998;28(3):235-242
Gemfibrozil-induced decrease in serum ubiquinone and α- and γ-tocopherol levels in men with combined hyperlipidaemia
Åberg F; Appelkvist EL; Bröijersen A; Eriksson M; Angelin B; Hjemdahl P; Dallner G
Article: THROMBOSIS AND HAEMOSTASIS. 1998;79(2):268-275
Platelet activity in vivo in hyperlipoproteinemia - Importance of combined hyperlipidemia
Bröijersén A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
Article: ATHEROSCLEROSIS. 1997;135(1):109-118
Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol - Results from the Angina Prognosis Study in Stockholm (APSIS)
Held C; Hjemdahl P; Rehnqvist N; Bjorkander I; Forslund L; Brodin U; Berglund L; Angelin B
Article: JOURNAL OF INTERNAL MEDICINE. 1997;242(4):329-337
The influence of age on low density lipoprotein metabolism: effects of cholestyramine treatment in young and old healthy male subjects
Ericsson S; Berglund L; Frostegard J; Einarsson K; Angelin B
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1997;17(10):2287-2292
Adipose tissue lipoprotein lipase and hormone-sensitive lipase - Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome
Reynisdottir S; Angelin B; Langin D; Lithell H; Eriksson M; Holm C; Arner P
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1997;17(9):1800-1805
Importance of estrogen receptors in hepatic LDL receptor regulation
Parini P; Angelin B; Rudling M
Article: ENDOCRINOLOGY. 1997;138(8):3276-3282
Lipoprotein metabolism in the fat Zucker rat: Reduced basal expression but normal regulation of hepatic low density lipoprotein receptors
Liao W; Angelin B; Rudling M
Article: HEPATOLOGY. 1997;25(6):1447-1450
Hepatic cholesterol metabolism in human obesity
Stahlberg D; Rudling M; Angelin B; Bjorkhem I; Forsell P; Nilsell K; Einarsson K
Article: JOURNAL OF CLINICAL INVESTIGATION. 1997;99(9):2239-2245
Growth hormone and bile acid synthesis - Key role for the activity of hepatic microsomal cholesterol 7 alpha-hydroxylase in the rat
Rudling M; Parini P; Angelin B
Article: ENDOCRINOLOGY. 1997;138(5):1863-1870
Novel effects of histamine on lipoprotein metabolism: Suppression of hepatic low density lipoprotein receptor expression and reduction of plasma high density lipoprotein cholesterol in the rat
Liao W; Rudling M; Angelin B
Article: LIPIDS. 1997;32(3):255-262
Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans - In vitro and in vivo studies
Vitols S; Angelin B; Juliusson GJ
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1997;17(2):273-278
No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia
Broijersen A; Eriksson M; Leijd B; Angelin P; Hjemdahl P
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1997;27(2):169-177
Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome
Stenvinkel P; Berglund L; Ericsson S; Alvestrand A; Angelin B; Eriksson M
Article: TRANSPLANTATION. 1997;63(1):74-80
Secretion and composition of bile after human liver transplantation - Studies on the effects of cyclosporine and tacrolimus
Ericzon BG; Eusufzai S; Soderdahl G; Duraj F; Einarsson K; Angelin B
Article: JOURNAL OF INTERNAL MEDICINE. 1997;241(1):59-69
Haemostatic markers, inflammatory parameters and lipids in male and female patients in the angina prognosis study in Stockholm (APSIS). A comparison with healthy controls
Held C; Hjemdahl P; Rehnqvist N; Wallen NH; Forslund L; Bjorkander I; Angelin B; Wiman B
Article: ENDOCRINOLOGY. 1997;138(1):289-295
Contrasting effects of growth hormone and insulin-like growth factor I on the biological activities of endotoxin in the rat
Liao W; Rudling M; Angelin B
Article: DRUG METABOLISM AND DISPOSITION. 1996;24(9):962-968
Metabolism and excretion of ropivacaine in humans
Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
Article: BIOLOGICAL PSYCHIATRY. 1996;40(4):302-304
Cholesterol lowering and cerebrospinal fluid neurotransmitters: Increased levels of the anxiogenic cholecystokinin-tetrapeptide during simvastatin administration to healthy male volunteers
Eriksson M; Eklundh T; Sjoberg S; Angelin B; Nordin C
Article: THROMBOSIS AND HAEMOSTASIS. 1996;76(2):171-176
Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII
Broijersen A; Hamsten A; Silveira A; Fatah K; Goodall AH; Eriksson M; Angelin B; Hjemdahl P
Article: JOURNAL OF LIPID RESEARCH. 1996;37(8):1733-1742
VLDL receptor mediates the uptake of human chylomicron remnants in vitro
Niemeier A; Gafvels M; Heeren J; Meyer N; Angelin B; Beisiegel U
Article: JOURNAL OF HEPATOLOGY. 1996;25(1):43-48
Bile acid kinetics and biliary lipid composition in cystic fibrosis
Strandvik B; Einarsson K; Lindblad A; Angelin B
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1996;81(7):2633-2637
Hormonal regulation of serum lipoprotein (a) levels: Effects of parenteral administration of estrogen or testosterone in males
Berglund L; Carlstrom K; Stege R; Gottlieb C; Eriksson M; Angelin B; Henriksson P
Article: AMERICAN JOURNAL OF PATHOLOGY. 1996;148(6):1985-1997
Expression of very low density lipoprotein receptor in the vascular wall - Analysis of human tissues by in situ hybridization and immunohistochemistry
Multhaupt HAB; Gafvels ME; Kariko K; Jin H; ArenasElliott C; Goldman BI; Strauss JF; Angelin B; Warhol MJ; McCrae KR
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1996;16(4):511-516
Gemfibrozil treatment of combined hyperlipoproteinemia - No improvement of fibrinolysis despite marked reduction of plasma triglyceride levels
Broijersen A; Eriksson M; Wiman B; Angelin B; Hjemdahl P
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1996;26(3):254-258
Growth hormone potentiates the in vivo biological activities of endotoxin in the rat
Liao W; Rudling M; Angelin B
Article: BIOCHEMICAL JOURNAL. 1996;313(Pt 3):873-878
Endotoxin suppresses rat hepatic low-density lipoprotein receptor expression
Liao W; Rudling M; Angelin B
Article: JOURNAL OF INTERNAL MEDICINE. 1996;239(2):177-180
Increased prevalence of atherosclerotic wall changes in patients with hyperlipidaemia after renal transplantation.
Jogestrand T; Fehrman-Ekholm I; Angelin B; Berglund L; Gäbel H
Article: JOURNAL OF CLINICAL INVESTIGATION. 1996;97(2):292-299
Regulation of rat hepatic low density lipoprotein receptors - In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I
Rudling M; Olivecrona H; Eggertsen G; Angelin B
Article: ENDOCRINOLOGY. 1995;136(9):3767-3773
GROWTH-HORMONE SPECIFICALLY STIMULATES THE EXPRESSION OF LOW-DENSITY-LIPOPROTEIN RECEPTORS IN HUMAN HEPATOMA-CELLS
PARINI P; ANGELIN B; LOBIE PE; NORSTEDT G; RUDLING M
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1995;15(7):847-849
HORMONAL-REGULATION OF SERUM LIPOPROTEIN(A) LEVELS - CONTRASTING EFFECTS OF GROWTH-HORMONE AND INSULIN-LIKE GROWTH-FACTOR-I
OLIVECRONA H; JOHANSSON AG; LINDH E; LJUNGHALL S; BERGLUND L; ANGELIN B
Article: JOURNAL OF CLINICAL INVESTIGATION. 1995;95(5):2161-2169
IMPAIRED ACTIVATION OF ADIPOCYTE LIPOLYSIS IN FAMILIAL COMBINED HYPERLIPIDEMIA
REYNISDOTTIR S; ERIKSSON M; ANGELIN B; ARNER P
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1995;80(4):1113-1117
GROWTH-HORMONE TREATMENT DOES NOT ALTER BILIARY LIPID-METABOLISM IN HEALTHY ADULT MEN
OLIVECRONA H; ERICSSON S; ANGELIN B
Article: HEPATOLOGY. 1995;21(4):1025-1030
INFLUENCE OF BEZAFIBRATE ON HEPATIC CHOLESTEROL-METABOLISM IN GALLSTONE PATIENTS - REDUCED ACTIVITY OF CHOLESTEROL 7-ALPHA-HYDROXYLASE
STAHLBERG D; REIHNER E; RUDLING M; BERGLUND L; EINARSSON K; ANGELIN B
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1995;25(4):271-280
STUDIES ON LIPOPROTEIN METABOLISM IN A FAMILY WITH JEJUNAL CHYLOMICRON RETENTION
NEMETH A; MYRDAL U; VERESS B; RUDLING M; BERGLUND L; ANGELIN B
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1995;15(1):121-127
GEMFIBROZIL ENHANCES PLATELET ACTIVITY IN PATIENTS WITH COMBINED HYPERLIPOPROTEINEMIA
BROIJERSEN A; ERIKSSON M; ANGELIN B; HJEMDAHL P
Visa fler

Alla övriga publikationer

Review: JOURNAL OF INTERNAL MEDICINE. 2023;294(5):582-604
Neurobiology of eating behavior, nutrition, and health
Stover PJ; Field MS; Andermann ML; Bailey RL; Batterham RL; Cauffman E; Fruhbeck G; Iversen PO; Starke-Reed P; Sternson SM; Vinoy S; Witte AV; Zuker CS; Angelin B
Review: JOURNAL OF INTERNAL MEDICINE. 2022;292(4):587-603
Nutrition and stem cell integrity in aging
Stover PJ; Field MS; Brawley HN; Angelin B; Iverson PO; Fruhbeck G
Other: JOURNAL OF INTERNAL MEDICINE. 2022;292(4):690
In memoriam: Rolf Hultcrantz (1949-2022) Obituary
Angelin B; Andersson J; Ekbom A; Melander O; Dahlqvist P; Smedby KE; Lerm M; Hedbom T; Cooper E; Forsberg N; de Faire U
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2019;286(6):723-725
How to handle hypertriglyceridaemia in acute pancreatitis - Still a vote for conservatives?
Eriksson M; Angelin B
Corrigendum: JOURNAL OF LIPID RESEARCH. 2018;59(11):2253
Erratum: Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol.
Ghosh M; Galman C; Rudling M; Angelin B
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2018;32:63
TESTOSTERONE REDUCES CIRCULATING PCSK9 BUT DOES NOT INFLUENCE CHOLESTEROL OR BILE ACID SYNTHESIS IN HEALTHY MALES
Laskar MG; Beckman L; Laskar A; Garevik N; Ekstrom L; Rudling M; Angelin B
Letter: JOURNAL OF INTERNAL MEDICINE. 2018;283(6):604-606
Unique case of cerebrotendinous xanthomatosis revisited: All the mutations responsible for this disease are present in the CYP27A1 gene
Jiao H; Olin M; Hansson M; Eggertsen G; Eriksson M; Angelin B; Bjorkhem I
Meeting abstract: ATHEROSCLEROSIS. 2017;263:E62
THE USE OF GENOTYPING AS A FIRST STEP IN MOLECULAR DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA
Benedek P; Angelin B; Duvefelt K; Hong J; Kere J; Rudling M; Eriksson M
Review: JOURNAL OF INTERNAL MEDICINE. 2017;281(6):534-553
Can LDL cholesterol be too low? Possible risks of extremely low levels
Olsson AG; Angelin B; Assmann G; Binder CJ; Bjoerkhem I; Cedazo-Minguez A; Cohen J; von Eckardstein A; Farinaro E; Mueller-Wieland D; Parhofer KG; Parini P; Rosenson RS; Starup-Linde J; Tikkanen MJ; Yvan-Charvet L
Editorial comment: TRENDS IN MOLECULAR MEDICINE. 2017;23(2):97-99
Metabolic Syndrome: One Speckled Stone Kills a Flock of Birds?
Bonde Y; Angelin B
Meeting abstract: ATHEROSCLEROSIS. 2016;252:E197
LIPIDS AND LIPOPROTEINS. POSTTRANSCRIPTIONAL REGULATION OF THE LDLR BY ACTH TREATMENT - IMPORTANCE OF PCSK9 IN LIVER WHILE IDOL TAKES THE SCENE IN THE ADRENALS
Laskar MG; Angelin B; Rudling M
Letter: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2015;100(12):L130-L131
Letter to the Editor: Potential Role for FGF21 as a Mediator of Thyroid Hormone Effects on Metabolic Regulation
Bonde Y; Angelin B; Rudling M
Review: CURRENT OPINION IN LIPIDOLOGY. 2013;24(4):327-331
Interstitial fluid lipoproteins
Lundberg J; Rudling M; Angelin B
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2013;273(1):3-5
Fifty years of lipoprotein(a) - the Magical Mystery Tour continues
Angelin B
Review: CELL METABOLISM. 2012;16(6):693-705
Circulating Fibroblast Growth Factors as Metabolic Regulators-A Critical Appraisal
Angelin B; Larsson TE; Rudling M
Review: NUTRITION REVIEWS. 2012;70 Suppl 1:S57-S86
Discussion from the 24(th) Marabou Symposium: Nutrition and the human microbiome.
Meeting abstract: JOURNAL OF HEPATOLOGY. 2012;56:S556
GUT MICROBIOTA REGULATES BILE ACID METABOLISM BY REDUCING THE LEVELS OF TAURO-BETAMURICHOLIC ACID, A NATURALLY OCCURRING FXR ANTAGONIST
Islam S; Felin J; Jantti S; Hyotylainen T; Wahlstrom A; Marschall H-U; Bamberg K; Angelin B; Oresic M; Backhed F
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2011;12(1):34
DIETARY SUGAR INCREASES LIVER CHOLESTEROL PARTLY THROUGH REDUCED BILIARY SECRETION OF CHOLESTEROL AND BY REDUCED SYNTHESIS OF BILE ACIDS
Lundberg J; Persson L; Galman C; Angelin B; Rudling M
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2011;12(1):13
REGULATION OF BILE ACID AND CHOLESTEROL METABOLISM BY ENDOGENOUS THYROID HORMONE IN HUMANS
Bonde Y; Angelin B; Rudling M
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2011;12(1):7
LIPID-LOWERING EFFECTS OF THE THYROID HORMONE ANALOGUE EPROTIROME REQUIRES FUNCTIONAL LDL RECEPTORS: STUDIES IN A HOMOZYGOUS FH PATIENT
Benedek P; Angelin B; Kristensen J; Rudling M; Eriksson M
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2011;12(1):23
ACUTE STIMULATION OF ENDOGENOUS ESTROGEN IN WOMEN ALTERS CHOLESTEROL METABOLISM AND REDUCES PCSK9 AND LDL CHOLESTEROL LEVELS
Persson L; Henriksson P; Westerlund E; Hovatta O; Angelin B; Rudling M
Review: CURRENT OPINION IN LIPIDOLOGY. 2010;21(6):499-506
Lipid lowering with thyroid hormone and thyromimetics
Angelin B; Rudling M
Editorial comment: OBSTETRICAL & GYNECOLOGICAL SURVEY. 2010;65(8):512-513
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
Ladenson PW; Kristensen JD; Ridgway EC; Olsson AG; Carlsson B; Klein I; Baxter JD; Angelin B
Letter: JOURNAL OF INTERNAL MEDICINE. 2009;265(2):296-298
Is endometroid cancer of the ovaries a late manifestation of Alstrom syndrome?
Moberg E; Hjerpe E; Ehrsson RJ; Moller C; Angelin B
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2008;9(1):33
CHOLESTEROL REGULATES ACAT2 GENE EXPRESSION AND ENZYME ACTIVITY IN HUMAN HEPATOMA CELLS
Pramfalk C; Angelin B; Eriksson M; Parini P
Corrigendum: JOURNAL OF INTERNAL MEDICINE. 2008;263(4):459
Circulating intestinal broblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man (vol 260, pg 530, 2006)
Lundasen T; Gaelman C; Angelin B; Rudling M
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):21
Cholestyramine up-regulates the expression of PCSK9 in human livers
Nilsson L-M; Abrahamsson A; Angelin B; Gustafsson U; Sahlin S; Parini P; Einarsson C
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):21
Reduction of ACAT2 is an important effect of cholesterol synthesis inhibition in human livers
Parini P; Gustafsson U; Einarsson C; Shalin S; Rudling M; Angelin B; Rudel LL; Eriksson M
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2007;8(1):43
HNF4 alpha is essential for ACAT2 regulation in human: Lesson from the mody patients
Pramfalk C; Karlsson E; Eriksson M; Angelin B; Groop L; Rudel LL; Parini P
Corrigendum: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006;348(1):326
Obesity and disturbed lipoprotein profile in estrogen receptor-α-deficient male mice (vol 278, pg 640, 2000)
Ohlsson C; Hellberg N; Parini P; Vidal O; Bohlooly-Y M; Rudling M; Lindberg MK; Warner M; Angelin B; Gustafsson J-A
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2006;7(3):188-189
Intestinal cholesterol absorption is not a major determinant for the age-induced increase in plasma cholesterol in rats
Galman C; Matasconi M; Parini P; Angelin B; Rudling M
Review: LAKARTIDNINGEN. 2006;103(10):751-752
[The apoB/apoA-I ratio is better myocardial infarction marker than lipids].
Walldius G; Angelin B; Eriksson M
Editorial comment: CELL METABOLISM. 2005;2(4):209-210
Telling the liver (not) to make bile acids: a new voice from the gut?
Angelin B
Letter: JOURNAL OF INTERNAL MEDICINE. 2005;257(3):313-314
Risk for fatal statin-induced rhabdomyolysis as a consequence of misinterpretation of 'evidence-based medicine'
Eriksson M; Angelin B; Sjöberg S
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2003;4(2):233
New molecular effects of cholesterol synthesis inhibition on hepatic cholesterol metabolism in humans
Eriksson M; Davis MA; Gustafsson U; Willingham MC; Einarsson C; Angelin B; Sahlin S; Rudel LL; Parini P
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2003;4(2):233
The hypophysectomized mouse - a feasible model for the further dissection of the role of the pituitary on lipid metabolism
Matasconi M; Angelin B; Rudling M
Review: LAKARTIDNINGEN. 2001;98(36):3788-3793
[Blood lipid derangement common in peripheral artery disease. Lipid-lowering agents may alleviate symptoms and slow the atherosclerotic process].
Bröijersén A; Wiklund B; Angelin B
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2001;250(1):1-2
Renewal of the Journal
Holm G; Angelin B; Fagrell B; De Faire U; Ljunghall S
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2001;249:1-2
Journal of Internal Medicine and the new century
Holm G; Angelin B; de Faire U; Fagrell B; Ljunghall S
Letter: LANCET. 2000;355(9198):148
Insulin-like growth factor I for growth hormone therapy
Liao W; Rudling M; Angelin B
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2000;247(1):1-2
Journal of Internal Medicine and the new century
Holm G; Angelin B; de Faire U; Fagrell B; Ljunghall S
Review: CURRENT OPINION IN LIPIDOLOGY. 1999;10(3):269-274
Bile acids and lipoprotein metabolism: a renaissance for bile acids in the post-statin era?
Angelin B; Eriksson M; Rudling M
Meeting abstract: ATHEROSCLEROSIS. 1999;144:93
Growth hormone infusion to LDL-receptor knock-out mice reduces plasma cholesterol and stimulates bile acid synthesis
Rudling M; Angelin B
Meeting abstract: ATHEROSCLEROSIS. 1999;144:112-113
VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression:: Involvement of the VLDL receptor
Nilsson L; Gåfvels M; Musakka L; Ensler K; Strickland DK; Angelin B; Hamsten A; Eriksson P
Published conference paper: GROWTH HORMONE & IGF RESEARCH. 1999;9:1-7
Effects of growth hormone on hepatic cholesterol metabolism. Lessons from studies in rats and humans
Rudling M; Parini P; Angelin B
Letter: TRANSPLANTATION. 1998;65(5):759
Dose-dependent reduction of bile secretion in cyclosporine-treated rats (reply)
Ericzon BG; Eusufzai S; Söderdahl G; Duraj F; Einarsson K; Angelin B
Review: CURRENT OPINION IN LIPIDOLOGY. 1997;8(6):337-341
Therapy for lowering lipoprotein(a) levels
Angelin B
Meeting abstract: ATHEROSCLEROSIS. 1997;134(1-2):188
Platelet function in hypercholesterolemia - importance of combined hyperlipidemia
Broijersen A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
Letter: JOURNAL OF HEPATOLOGY. 1997;26(5):1157
Bile acid kinetics and biliary lipid composition in cystic fibrosis - Reply
Strandvik B; Einarsson K; Lindblad A; Angelin B
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 1996;239(1):1-2
Journal of Internal medicine - A journal for the internist
Holm G; Angelin B; DeFaire U; Fagrell B; Ljunghall S
Letter: NEPHRON. 1996;72(3):483
Decreased cyclosporine levels during gemfibrozil treatment of hyperlipidemia after kidney transplantation
FehrmanEkholm I; Jogestrand T; Angelin B
Review: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1995;25(4):215-224
STUDIES ON THE REGULATION OF HEPATIC CHOLESTEROL-METABOLISM IN HUMANS
ANGELIN B
Addendum: ENDOCRINOLOGY. 1995;136(2):795
Cloning of a complementary deoxyribonucleic acid encoding the murine homolog of the very low density lipoprotein/apolipoprotein-E receptor: expression pattern and assignment of the gene to mouse chromosome 19".
Gafvels ME; Paavola LG; Boyd CO; Nolan PM; Wittmaack F; Chawla A; Lazar MA; Bucan M; Angelin B; Strauss JF
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(1):1125
FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man.
Söderdahl G; Groth CG; Angelin B; Duraj F; Einarsson K; Ericzon BG
Visa fler

Anställningar

Professor, Senior, Medicin, Huddinge, Karolinska Institutet, 2024-2025
Professor, Medicin, Huddinge, Karolinska Institutet, 2020-2024

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Nyheter från KI

Kalenderhändelser från KI